原发性脑肿瘤的流行病学:一项全国性基于人群的研究
该研究在法国全国范围内纳入2006至2011年间新诊断且组织学确诊的原发性中枢神经系统肿瘤(PCNST)患者共57,816例,男性占46.4%,诊断中位年龄56岁(范围0-99岁)。组织学确诊PCNST的粗发病率为15.5/10万(每10万人年),按美国、欧洲和世界参考人口标化率分别为14.1/10万、14.5/10万和12.0/10万。研究详细报告了143种组织学亚型的发病率、性别比、诊断中位年龄、冷冻保存样本数和手术类型,为首次在国家级层面描述所有组织学亚型(含罕见肿瘤)的发病率和流行病学数据。
要点
- 法国2006-2011年组织学确诊PCNST共57,816例,粗发病率15.5/10万(每10万人年)。
- 按美国、欧洲、世界参考人口标化发病率分别为14.1/10万、14.5/10万、12.0/10万。
- 研究详细报告了143种组织学亚型的发病率等流行病学数据,包括罕见肿瘤。
核心结论
- 本研究首次在国家级层面描述了所有组织学亚型(包括罕见肿瘤)PCNST的发病率和流行病学数据,其方法学确保了组织学确诊案例数据收集的全面性。
研究设计与样本
- 研究为法国全国性基于人群的研究,纳入2006至2011年间所有新诊断且组织学确诊的PCNST患者,共57,816例。
主要发现
- 患者中男性占46.4%,诊断中位年龄56岁(范围0-99岁)。
- 组织学确诊PCNST的粗发病率为15.5/10万(每10万人年)。
- 按美国、欧洲和世界参考人口标化发病率分别为14.1/10万、14.5/10万和12.0/10万。
- 23.4%的样本进行了冷冻保存,79.1%的病例接受了切除术。
- 研究详细报告了143种组织学亚型的发病率等数据,例如间变性神经节胶质瘤(美国参考人口)发病率为0.018/10万、恶性脑膜瘤为0.054/10万、血管外皮细胞瘤为0.036/10万。
关键数值与推荐
- 组织学确诊PCNST的粗发病率为15.5/10万(每10万人年)。
- 按美国参考人口标化发病率为14.1/10万,欧洲参考人口为14.5/10万,世界参考人口为12.0/10万。
- 23.4%的样本进行了冷冻保存,79.1%的病例接受了切除术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary central nervous system tumors (PCNST) are rare tumors responsible for high mortality and morbidity. Their epidemiology is poorly known, and clinical data are scarcely analyzed at a national level. In this study, we aimed at providing descriptive epidemiological data and incidence rates for all histological subtypes of PCNST according to the WHO classification. We conducted a nationwide population-based study of all newly diagnosed and histologically confirmed PCNST in France, between 2006 and 2011. A total of 57,816 patients were included: male 46.4%, median age at diagnosis 56 years old (range 0-99). For all newly diagnosed PCNST with histological confirmation the crude incidence rate was 15.5/105 per 100,000 person-years. To enable international comparisons, standardized rates were calculated: 14.1/105 (population of reference: USA), 14.5/105 (population of reference: Europe), and 12.0/105 (population of reference: world). 23.4% of samples were cryopreserved. Resection was performed in 79.1% of cases. Results are detailed (incidence rate, sex ratio, median age at diagnosis, number of cryopreserved samples, and type of surgery) for each of the 143 histological subtypes of PCNST, including all rare tumors. For example, incidence rates (population of reference: USA) were 0.018/105 for anaplastic gangliogliomas, 0.054/105 for malignant meningiomas, and 0.036/105 for hemangiopericytomas. Our study is the first to describe incidence rates and epidemiological data for all histological subtypes of PCNST, including rare tumors, at a national level. Its methodology ensures the exhaustiveness of the data collection for histologically-proven cases. Histological population-based studies have many perspectives in the field of clinical epidemiology and research.
引用
- Darlix A, Zouaoui S, Rigau V, et al. Epidemiology for primary brain tumors: a nationwide population-based study. J Neurooncol. 2016. PMID: 27853959. doi:10.1007/s11060-016-2318-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。